trial
as of 2026-07-01Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation
NCTId NCT04184830
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
49 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2011-09
Primary completion
2014-10
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Indications
Sponsors
King's College LondonLead Sponsor
Sites
0 total
Facts & assertions
4 sourced
Enrollment
49
Phase
NA
Primary Completion Date
2014-10
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication